The Alopecia Treatment Market To See Growth Based On Immediate Adoption Of Advancements (Reaching US$ 9.5 Billion) Between 2020 to 2030

The growing number of cancer case increasing the demand for the chemotherapy drug administration. Chemotherapy causes the number of side effects among which alopecia is one of the most common side effects. Chemotherapy-induced alopecia is a common problem associated with a different kind of chemotherapy. Scalp cooling approach is gaining popularity to reduce chemotherapy-induced alopecia. Scalp cooling approach is work on the temperature reduction principle.

Reduction in the temperature results in decreased blood flow to the scalp is and reduce hair loss. Since 1970 Scalp cooling has been practiced for chemotherapy-induced alopecia treatment in Europe.

Due to safety concern scalp cooling has been some degree of uses in the United States. Only two automated scalp cooling systems are recently approved for the chemotherapy-induced alopecia treatment in the United States for solid tumor malignancies.

Get Sample Copy of the Report@ https://www.persistencemarketresearch.com/samples/30653

Increasing prevalence of cancer expected to favor demand chemotherapy-induced alopecia treatment as increasing treatment-seeking rate and adoption of the chemotherapy for treatment. Growing treatment affordability rate and awareness rate expected to boost up the growth of the chemotherapy-induced alopecia treatment market. Increasing genetic disorder and hereditary cancer expected to propel the growth of the chemotherapy-induced alopecia treatment market.

Growing new product development activities and increasing FDA approvals expected to boost up the growth of the chemotherapy-induced alopecia treatment market. Previously automated scalp cooling systems was not approved in the United States. Recently FDA approved two automated scalp cooling systems for chemotherapy-induced alopecia treatment and prevention.

In December 2015, FDA approved DigniCap system for chemotherapy-induced alopecia treatment. In April 2017, Paxman scalp cooling system was cleared by the FDA. Moreover, side effects associated with scalp cooling such as headache, scalp pain, and chills are restraining the growth of the chemotherapy-induced alopecia treatment market.

Market Segmentation:

By Product Type
Automated Scalp Cooling Systems
Manual Cold Cap Systems

By End-User
Hospitals
Cancer Therapy Centers
Home Care Settings

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/30653

Scalp cooling chemotherapy-induced alopecia treatment product is available in two type automated scalp cooling systems and manual cold cap systems. Till now, manual cold cap systems are not approved for clinical use in the United States. Increasing non-profit organization funding for the chemotherapy-induced alopecia treatment expected to favour the growth of the market.

Initiatives such as Hair to Stay, Cold Capital Fund, Hope for Hair expected to boom up the demand for the chemotherapy-induced alopecia treatment products. Manufacturers are focusing on to develop an effective option for the chemotherapy-induced alopecia treatment. The manufacturers developed a sensor-controlled scalp cooling system based on patients age and chemotherapy regimen.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/30653

Some of the players operating in the global chemotherapy-induced alopecia treatment market are Dignitana AB, Paxman Coolers Ltd, Penguin Cold Caps, Arctic Cold Caps, LLC.., Wishcaps, Warrior Caps, LLC and others. Manufacturers are focusing on new product launch and expansion of their offering in emerging countries such as India and China. Manual cold cap systems are focusing to get regulatory approval in the United States.

Access Related Reports-

Non Melanoma Skin Cancer Market: https://www.persistencemarketresearch.com/market-research/non-melanoma-skin-cancer-market.asp

Home Infusion Therapy Market: https://www.persistencemarketresearch.com/market-research/home-infusion-therapy-market.asp

Fibromyalgia Treatment Market: https://www.persistencemarketresearch.com/market-research/fibromyalgia-treatment-market.asp

Hyperthermia Treatment For Cancer Market: https://www.persistencemarketresearch.com/market-research/hyperthermia-treatment-for-cancer-market.asp

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.